Is doxycycline safe to use during pregnancy, and what alternative antibiotics are recommended?

Doxycycline and Pregnancy

Doxycycline should generally be avoided during pregnancy, particularly in the second and third trimesters, due to risks of tooth discoloration, bone growth suppression, and potential maternal hepatotoxicity, though it may be used for life-threatening infections when safer alternatives are unavailable. 1, 2

General Safety Profile

The FDA classifies doxycycline as Pregnancy Category D 3. While an expert review concluded that therapeutic doses are "unlikely to pose a substantial teratogenic risk," the data remain insufficient to definitively state there is no risk 3. A recent large population-based cohort of 265,686 pregnancies found no association between first-trimester doxycycline exposure and major congenital malformations (adjusted RR 1.07,95% CI 0.93-1.23) 4. However, other studies have identified concerning associations with cardiovascular malformations and pregnancy loss 5, 6.

Trimester-Specific Risks

First Trimester

• Possibly safe for short courses (7-14 days) if clinically necessary 1, 7
• One case-control study showed weak association with neural tube defects (based on only 2 cases) 3
• A small prospective study of 43 women treated for 10 days in early first trimester reported normal infants at 1 year 3

Second and Third Trimesters

• Should be avoided 1
• Associated with permanent tooth discoloration in developing dentition 1, 8
• Risk of transient bone growth suppression 1
• Potential for maternal fatty liver of pregnancy (though this was primarily with high-dose IV tetracycline, not doxycycline) 1, 9
• Third-trimester exposure linked to very low birthweight 4

When Doxycycline May Be Justified

For life-threatening infections where safer alternatives are ineffective or unavailable, doxycycline use may be warranted despite pregnancy 8, 9:

• Rocky Mountain Spotted Fever (RMSF) and other tickborne rickettsial diseases: Doxycycline is the drug of choice even in pregnancy, as untreated disease poses greater risk to mother and fetus than the medication 8, 9
• Severe ehrlichiosis or anaplasmosis: Doxycycline remains preferred 9
• Tularemia: Fluoroquinolones or gentamicin are preferred, but doxycycline is an alternative option 5
• Anthrax exposure: May be used for bioterrorism-related exposures when benefits outweigh risks 7

Recommended Safer Alternatives

First-line antibiotics during pregnancy 1, 2:

• Amoxicillin (Category A/B): Compatible with pregnancy
• Cephalexin (Category B1/B): Safe, evidence-based choice
• Azithromycin (Category B1/B): Probably safe (very low risk of infantile hypertrophic pyloric stenosis if used during first 13 days of breastfeeding)
• Clindamycin (Category B): Compatible, though data less robust as monotherapy

Antibiotics to avoid 1, 2:

• Erythromycin: Avoid due to risk of elevated liver enzymes 2
• Co-trimoxazole (TMP-SMX): Associated with preterm birth, low birthweight, kernicterus 2
• Metronidazole: Risk of low birthweight and neuroblastoma 2
• Fluoroquinolones: Generally avoided, though recent data suggest lower risk than previously thought 1

Breastfeeding Considerations

Short-term doxycycline use (3-4 weeks) is considered probably safe during lactation 1, 9. Doxycycline is excreted into breast milk at low levels, but the extent of infant absorption is unknown 3. The American Academy of Pediatrics lists tetracycline as "usually compatible with breastfeeding" 9.

Clinical Decision-Making Algorithm

1. Identify the infection: Is it life-threatening (RMSF, severe ehrlichiosis, anthrax)?

   • Yes: Doxycycline may be justified; counsel patient on risks vs. benefits
   • No: Proceed to step 2

2. Consider trimester:

   • First trimester: Short courses (≤14 days) possibly acceptable if no alternatives
   • Second/third trimester: Strongly avoid due to tooth/bone effects

3. Evaluate alternatives:

   • Use amoxicillin, cephalexin, azithromycin, or clindamycin when appropriate for the infection
   • For RMSF in pregnancy: Chloramphenicol is an alternative but has risks (gray baby syndrome in third trimester) 9
   • For anaplasmosis: Rifampin may be considered 9

4. If doxycycline is necessary:

   • Use shortest effective duration
   • Provide detailed counseling about risks
   • Document shared decision-making
   • Avoid doses exceeding standard therapeutic levels

Common Pitfalls

• Assuming all tetracyclines carry equal risk: Doxycycline binds calcium less avidly than older tetracyclines, but this doesn't eliminate risk 10
• Overlooking disease severity: For RMSF and similar infections, untreated maternal disease poses greater fetal risk than doxycycline 8, 9
• Failing to counsel patients: The 2025 hidradenitis suppurativa guidelines strongly recommend avoiding doxycycline in pregnancy (strong recommendation, low quality evidence) 2, reflecting consensus that safer alternatives should be prioritized
• Confusing PEP with treatment: Recent CDC guidelines list doxycycline as an alternative (not first-line) for post-exposure prophylaxis in pregnant women 5